Sven Klussmann
Director Técnico/Científico/I+D en NOXXON Pharma AG .
Cargos activos de Sven Klussmann
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Director Técnico/Científico/I+D | 01/01/1997 | - |
| Presidente | 01/01/1997 | 16/11/2009 |
Historial de carrera de Sven Klussmann
Antiguos cargos conocidos de Sven Klussmann.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TME PHARMA N.V. | Director Técnico/Científico/I+D | 01/01/1997 | - |
| Fundador | 01/01/1997 | - |
Formación de Sven Klussmann.
| Freie Universität Berlin | Undergraduate Degree |
Estadísticas
Internacional
| Alemania | 4 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| President | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| TME PHARMA N.V. | Health Technology |
| Empresas privadas | 1 |
|---|---|
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Health Technology |
- Bolsa de valores
- Insiders
- Sven Klussmann
- Experiencia
